Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (91-100 of 220) with videos related to

Pageof 22
Sort By:
Cancer|January 23, 2020
A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumorsVictor M Santana, Natasha Sahr, Ruth G Tatevossian, et al.
Neuro-Oncology|September 10, 2013
Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology GroupTobey J MacDonald, Gilbert Vezina, Clinton F Stewart, et al.
Journal of Liquid Chromatography & Related Technologies|August 22, 2017
Determination of Methotrexate, 7-Hydroxymethotrexate, and 2,4-Diamino-N<sup>10</sup>-methylpteroic Acid by LC-MS/MS in Plasma and Cerebrospinal Fluid and Application in a Pharmacokinetic Analysis of High-Dose MethotrexateMichael S Roberts, Nicholas S Selvo, Jessica K Roberts, et al.
Cancer|March 6, 2008
Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapseNobuko Hijiya, Clinton F Stewart, Yinmei Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenograftsMarkos Leggas, Clinton F Stewart, Michael H Woo, et al.
Cancer Research|May 13, 2010
Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomasAngel M Carcaboso, Mohamed A Elmeliegy, Jun Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular RetinoblastomaRachel C Brennan, Ibrahim Qaddoumi, Shenghua Mao, et al.
Pediatric Blood & Cancer|June 16, 2007
Reducing irinotecan-associated diarrhea in childrenLars M Wagner, Kristine R Crews, Clinton F Stewart, et al.
Pediatric Blood & Cancer|March 8, 2018
Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine gliomaAlberto Broniscer, Sujuan Jia, Belinda Mandrell, et al.
Cancer|November 4, 2009
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemiaHiroto Inaba, Clinton F Stewart, Kristine R Crews, et al.
Pageof 22

Showing results (91-100 of 220) with videos related to

Sort By:
Pageof 22
Cancer|January 23, 2020
A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumorsVictor M Santana, Natasha Sahr, Ruth G Tatevossian, et al.
Neuro-Oncology|September 10, 2013
Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology GroupTobey J MacDonald, Gilbert Vezina, Clinton F Stewart, et al.
Journal of Liquid Chromatography & Related Technologies|August 22, 2017
Determination of Methotrexate, 7-Hydroxymethotrexate, and 2,4-Diamino-N<sup>10</sup>-methylpteroic Acid by LC-MS/MS in Plasma and Cerebrospinal Fluid and Application in a Pharmacokinetic Analysis of High-Dose MethotrexateMichael S Roberts, Nicholas S Selvo, Jessica K Roberts, et al.
Cancer|March 6, 2008
Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapseNobuko Hijiya, Clinton F Stewart, Yinmei Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenograftsMarkos Leggas, Clinton F Stewart, Michael H Woo, et al.
Cancer Research|May 13, 2010
Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomasAngel M Carcaboso, Mohamed A Elmeliegy, Jun Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular RetinoblastomaRachel C Brennan, Ibrahim Qaddoumi, Shenghua Mao, et al.
Pediatric Blood & Cancer|June 16, 2007
Reducing irinotecan-associated diarrhea in childrenLars M Wagner, Kristine R Crews, Clinton F Stewart, et al.
Pediatric Blood & Cancer|March 8, 2018
Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine gliomaAlberto Broniscer, Sujuan Jia, Belinda Mandrell, et al.
Cancer|November 4, 2009
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemiaHiroto Inaba, Clinton F Stewart, Kristine R Crews, et al.
Pageof 22